Literature DB >> 32825963

Pathologic features of COVID-19: A concise review.

Mohammadreza Tabary1, Shaghayegh Khanmohammadi2, Farnaz Araghi3, Sahar Dadkhahfar3, Seyed Mohammad Tavangar4.   

Abstract

The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), first appeared in December 2019, in Wuhan, China and evolved into a pandemic. As Angiotensin-Converting Enzyme 2 (ACE2) is one of the potential target receptors for SARS-CoV-2 in human body, which is expressed in different tissues, multiple organs might become affected. In the initial phase of the current pandemic, a handful of post-mortem case-series revealed COVID-19-related pathological changes in various organs. Although pathological examination is not a feasible method of diagnosis, it can elucidate pathological changes, pathogenesis of the disease, and the cause of death in COVID-19 cases. Herein, we thoroughly reviewed multiple organs including lung, gastrointestinal tract, liver, kidney, skin, heart, blood, spleen, lymph nodes, brain, blood vessels, and placenta in terms of COVID-19-related pathological alterations. Also, these findings were compared with SARS and MERS infection, wherever applicable. We found a diverse range of pathological changes, some of which resemble those found in SARS and MERS.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  COVID-19; Histopathology; Pathology; SARS-CoV-2

Mesh:

Substances:

Year:  2020        PMID: 32825963      PMCID: PMC7334952          DOI: 10.1016/j.prp.2020.153097

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


Introduction

The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), first appeared in December 2019, in Wuhan, China and evolved into a pandemic [6]. So far, almost 10 million infected cases and 500,000 consequent deaths have been reported globally. SARS-CoV-2 is the seventh member of coronavirus family leading to a wide range of clinical symptoms including respiratory, hepatic, enteric, and neurologic manifestations. Earlier in the last two decades, two other members of this family, severe acute respiratory syndrome coronavirus (SARS‐CoV) and the Middle East respiratory syndrome coronavirus (MERS‐CoV), leaded to global outbreaks with high mortality and morbidity [16,20]. Sharing similar clinical manifestations, these coronaviruses may resemble each other in terms of pathogenesis and pathological features [21]. Besides, Angiotensin-Converting Enzyme 2 (ACE2) is one of the potential target receptors for SARS-CoV-2 in human body, which is expressed in different tissues including lung, gastrointestinal tract, vessels, brain, liver, kidney, spleen, and skin [9,13]. This may lead to possible short-term and long-term involvement of multiple human organs. Based on the autopsy results SARS-CoV-2 seems to affect several organs, such as lung, heart, blood vessels, etc [24]. Previous post-mortem case-series revealed a diverse range of pathological changes after being infected with SARS-CoV-2. Currently, diagnosis of COVID-19 is mainly based on CT-imaging, laboratory tests, and history taking. Although pathological examination is not a feasible method of diagnosis, it can elucidate pathological changes, pathogenesis of the disease, and the cause of death in COVID-19 cases [22]. Herein, we discuss histopathologic changes in different tissues after being infected by SARS-CoV-2 to broaden the knowledge of SARS-CoV-2 pathological changes.

Lung

Since SARS-CoV-2 is considered as a respiratory virus, is one of the well-studied organs in autopsies and biopsies of infected cases. Acute respiratory distress syndrome (ARDS) and pneumonia are usually the clinical diagnosis of infected cases [15,38]. In autopsy samples, macroscopic findings revealed an increase in lung weight, copious amounts of gray-white viscous fluid, vascular engorgement, consolidation, edema, pleurisy, mildly erythematous trachea, presence of white mucous in lungs, and pink froth in airways with dark-colored hemorrhage [10,14,38]. These findings may vary regarding the phenotype of the virus, explained as L and H phenotypes. L type is described with the following characteristics: low elastance, a low ventilation-to-perfusion ratio, a low lung weight and a low lung recruitability. However, H type is described with high elastance, a high right-to-left shunt, a high lung weight and a high lung recruitability. Also, H type tends to accompany more adverse outcomes compared to L type [5]. Microscopic autopsy findings have also been reported with a great variability. Diffuse alveolar damage (DAD), infiltration of lymphocytes in interstitial regions, giant pneumocytes adjacent to multinucleated giant cells, hyperplasia of pneumocytes, intra-alveolar fibrin deposition, exudate formation, lymphocytic inflammation, loose connective tissue within the alveolar ducts and bronchioles, intra-alveolar fibrin surrounded by fibroblasts, viral particles within pneumocytes, and hyaline membrane formation were the most commonly observed histopathological changes described by previous studies [3,5,14,15,38]. In addition, cytoplasmic vacuolization in pulmonary arteries, megakaryocyte with multinuclear appearance within the branching small vessels (in exudative phase), pulmonary microangiopathy, fibrin clotting within small capillaries around alveoli, capillary congestion (in exudative phase), small vessel thrombosis with alveolar hemorrhage, and thickening of alveolar capillaries in lungs were found in different post-mortem studies [3,5,10,18]. Similar findings have been reported in SARS, and Middle East Respiratory Syndrome (MERS). predominant visceral macroscopic changes in fatal SARS‐CoV cases have been reported as edematous lungs with increased gross weights and multiple areas of congestion, enlargement of lymph nodes in the pulmonary hila and the abdominal cavity [7,26]. Also, bronchial epithelial denudation, loss of cilia, and squamous metaplasia were present among microscopic findings [26]. Similar findings were observed in MERS-CoV, including exudative diffuse alveolar damage with hyaline membranes, pulmonary edema, type II pneumocyte hyperplasia, interstitial pneumonia and multinucleate syncytial cells [1,25]. Both SARS‐CoV and MERS-CoV particles were present in pneumocytes in electron microscopic examination [30]; same results were observed for SARS-CoV-2 [40]. In addition, DAD is among the most common pathological findings reported in Human Influenza A (H1N1), which tends to be commonly present among SARS-CoV-2 cases [23].

Gastrointestinal (GI) tract

COVID-19 infection may also affect since ACE2 is abundantly present in the enterocytes [13]. SARS-CoV-2 has been found in stool specimen and diarrhea was reported in several infected cases [36,37]. Endoscopy was performed on patients and hematoxylin and eosin (H&E) staining revealed no significant damage in mucous epithelium of GI tract; however, infiltration of lymphocytes in the esophageal squamous epithelium, and lamina propria of the stomach, duodenum, and rectum was seen. In addition, interstitial edema was observed. Besides, viral nucleocapsid protein was seen in glandular epithelial cell of stomach, duodenum, and rectum, but not in the esophageal epithelium [36]. As ACE2 is highly distributed in glandular epithelial cell [36], it is worth mentioning that there are evidences suggesting that SARS-CoV-2 may cause acute and chronic sialadenitis in infected cases [35].

Liver

Moreover, high level of hepatic enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) in infected cases suggests involvement of tissue. Macroscopic findings of autopsy samples showed dark red liver with hepatomegaly. Histopathologic examinations showed hepatocyte degeneration with lobular focal necrosis, congestion of hepatic sinuses with microthrombus, fibrosis of portal tract, proliferation of portal vein branches, and mononuclear leukocyte and neutrophil infiltration within the portal area [19,31]. Sonzogni et al. found alteration of vascular structure, both acute (thrombosis, luminal ectasia) and chronic (fibrous thickening of vascular wall or phlebosclerosis, and abnormal asset of portal intrahepatic system). Atypical arrangement of intrahepatic blood vessels was also observed with CD34 staining, decorating a peri-portal network of sinusoidal vessels, which may show increased arterial pressure [31]. Also, biopsy findings of patients with Covid-19 revealed moderate microvascular steatosis and mild lobular and portal activity. It is also worth mentioning that SARS and MERS showed similar liver pathological characteristics to SARS-CoV-2 [39].

Kidney

COVID-19 may also involve the tissue of infected cases. Histopathologic findings of biopsy samples showed proximal acute tubule injury (ATI) in renal tissues. Luminal brush border sloughing, vacuole degeneration, tubular necrosis, infiltration of lymphocytes (mainly CD8 + T cells) and CD68+ macrophages in the tubulointerstitial and sub-capsular area, interstitial fibrosis in cortical parenchyma, strong complement membrane attack complex (MAC) deposition in tubules, mild focal tubular atrophy, hypertrophy and hyperplasia of glomerular epithelial cells, hemosiderin granules in tubular epithelium, and podocyte vacuolation were reported. Moreover, infrastructural changes were also present; cellular swelling in infected renal tissues with the expansion of mitochondria and lysosome, as well as dilation of smooth endoplasmic reticulum (SER) and rough endoplasmic reticulum (RER) were seen among samples [6,28,32]. In addition, vascular analysis visualized infiltration of inflammatory cells in the arcuate artery, and dilated and swollen capillary vessels in glomeruli. Regarding vascular changes, segmental fibrin thrombus in glomerular capillary loops, endothelial hyperplasia, and foamy-like appearance of endothelial cells were seen in microscopic analysis [6,32]. It is also worth mentioning that collapsing glomerulopathy (CG) could be the result of COVID-19 infection in several patients [28]. Previous studies on MERS-CoV reported acute tubulointerstitial nephritis and acute tubular sclerosis with proteinaceous cast formation [4].

Skin

COVID-19 also causes alterations. Skin macroscopic manifestations can be divided into viral exanthems (morbilliform rash, petechial rash co-existing with thrombocytopenia, erythematous-to-purpuric coalescing macules, widespread urticaria, and varicella-like vesicles) and vasculopathy-related skin manifestations (peripheral cyanosis with bullae and dry gangrene, transient unilateral livedo reticularis, and red papules on fingers resembling chilblains) [33]. A recent study classified skin lesions as acral areas of erythema with vesicles or pustules (i.e. Pseudo-chilblain, appearing late in the evolution of the disease), vesicular eruptions (early manifestation), urticarial lesions, maculopapular eruptions (most common lesions), and livedo or necrosis [11]. Regarding histopathological findings of biopsy samples, superficial and deep perivascular dermatitis, blood vessels surrounded by lymphocytes, focal acantholytic suprabasal clefts, dyskeratotic and ballooning herpes-like keratinocytes, necrosis of keratinocytes, mucin deposition in the dermis and hypodermis, and nests of Langerhans cells within the epidermis were reported among infected cases. Moreover, thrombus formation and extravasation of erythrocyte in mid-dermis blood vessels was found. Also, swollen thrombosed blood vessels in the dermis with the presence of eosinophils, neutrophils and nuclear debris was visualized [8,12].

Heart

COVID-19 also tends to change the macroscopic and microscopic features of the . Cardiomegaly and right ventricular dilation were prominent in some patients. Autopsies showed firm myocardium with red-brown appearance without injury. Microscopic findings revealed dispersed area of myocyte necrosis near to lymphocytes in few cases (suggesting microvascular blood supply failure in heart). Also, typical viral myocarditis pattern (brisk lymphocytic inflammatory infiltrate) was not present [10]. Infiltration of mononuclear leukocytes in interstitial areas was also reported by one study [37].

Blood

specimen is used to detect SARS-CoV-2 in suspected cases. Although leukopenia and lymphocytopenia occurred in infected cases, blood flow cytometry detected high levels of T-helper 17 and CD8 + T-cells [19]. Interestingly, other flow cytometric analyses revealed that monocytes count did not change in patients; however, they were larger in comparison to normal monocytes (the presence of high forward scatter [FSC-high] monocytes, which are consistent with an inflammatory phenotype) [41]. Besides, autopsy findings of bone marrow showed reactive left-shifted myelopoiesis and hyperplasia of CD8 + T cells [24].

Spleen and lymph nodes

Studies showed that viral nucleocapsid protein (NP) could be seen in tissue. Viral NP+ Cells were distributed in both red (primarily) and white pulp. Also, NP antigen was found in macrophages within the lymph nodes [9]. Histopathologic examinations of autopsy samples showed reduction of cell composition, atrophy of white pulp, neutrophil and plasma cell infiltration, reduction or absence of lymph follicles, increase in red pulp to white pulp proportion, reduction of T and B cells due to necrosis and apoptosis, and atrophy of corpuscles in the spleen of infected cases. Besides, in microscopic examination of vessels, splenic infarction due to arterial thrombosis, CD20 + B cells surrounding splenic artery, and proliferation of fibrotic tissues in sinuses were seen [9,38]. In addition, congestion and hemorrhagic appearance were visualized in the spleen [9]. However, previous studies showed a diminished spleen size and reduced spleen weights among SARS-CoV cases [7].

Brain

Viral particles of SARS-CoV-2 were also found in the frontal lobe of the and brain capillary endothelial cells [27]. Moreover, Histopathologic examination of autopsy samples of the brain showed no infiltration of inflammatory cells or neural cell degeneration. However, mild hypoxic manifestations were present in several autopsies [24]. Also, microglia and type I astrocytes, infected by murine coronavirus (MHV-A59), can produce pro-inflammatory cytokines [17]. Autopsy findings of a patient with post-operational complications, positive for Covid-19, showed hemorrhagic white matter lesions with axonal injuries and white blood cells such as macrophages. Perivascular acute disseminated encephalomyelitis (ADEM)-like appearance as well as neocortical microscopic infarcts were also seen in autopsy findings [29].

Blood vessels and placenta

Pathological findings of SARS-CoV-2 have been discussed in each section, but there are also other tissue alternations due to SARS-CoV-2 in blood vessels. Autopsy findings revealed accumulation of inflammatory cells and endothelial and inflammatory cell death, which are the features of endotheliitis [34]. SARS-Cov-2 also alter placenta in pregnant women. Pathologic findings of biopsy samples revealed low grade fetal vascular malperfusion, intramural fibrin deposition, intramural nonocclusive thrombi, and meconium macrophages. In human SARS, fetal thrombotic vasculopathy has also been reported [2]. A summary of microscopic COVID-19-related findings is illustrated in Fig. 1 .
Fig. 1

A summary of most common microscopic findings of COVID-19 in various organs.

MAC: Membrane Attack Complex; ADEM: Acute Disseminated Encephalomyelitis.

A summary of most common microscopic findings of COVID-19 in various organs. MAC: Membrane Attack Complex; ADEM: Acute Disseminated Encephalomyelitis.

Conclusion

COVID-19 infection affects not only the lung but also other organs, such as GI tract, liver, kidney, skin, heart, blood, and spleen. We found a diverse range of pathological changes, some of which resemble those found in SARS and MERS. In addition to pulmonary adverse reactions, short and long-term effects of the SARS-CoV-2 on other organs should be considered.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  33 in total

1.  Emerging diseases. Researchers scramble to understand camel connection to MERS.

Authors:  Kai Kupferschmidt
Journal:  Science       Date:  2013-08-16       Impact factor: 47.728

2.  Lung pathology in fatal novel human influenza A (H1N1) infection.

Authors:  Thais Mauad; Ludhmila A Hajjar; Giovanna D Callegari; Luiz F F da Silva; Denise Schout; Filomena R B G Galas; Venancio A F Alves; Denise M A C Malheiros; Jose O C Auler; Aurea F Ferreira; Marcela R L Borsato; Stephania M Bezerra; Paulo S Gutierrez; Elia T E G Caldini; Carlos A Pasqualucci; Marisa Dolhnikoff; Paulo H N Saldiva
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

3.  Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.

Authors:  R Ross Reichard; Kianoush B Kashani; Nicholas A Boire; Eleni Constantopoulos; Yong Guo; Claudia F Lucchinetti
Journal:  Acta Neuropathol       Date:  2020-05-24       Impact factor: 17.088

4.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

5.  Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?

Authors:  Chenxing Wang; Heming Wu; Xu Ding; Huan Ji; Pengfei Jiao; Haiyang Song; Sheng Li; Hongming Du
Journal:  Med Hypotheses       Date:  2020-04-24       Impact factor: 1.538

Review 6.  Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.

Authors:  Jia Liu; Xin Zheng; Qiaoxia Tong; Wei Li; Baoju Wang; Kathrin Sutter; Mirko Trilling; Mengji Lu; Ulf Dittmer; Dongliang Yang
Journal:  J Med Virol       Date:  2020-02-21       Impact factor: 2.327

7.  Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014.

Authors:  Dianna L Ng; Farida Al Hosani; M Kelly Keating; Susan I Gerber; Tara L Jones; Maureen G Metcalfe; Suxiang Tong; Ying Tao; Negar N Alami; Lia M Haynes; Mowafaq Ali Mutei; Laila Abdel-Wareth; Timothy M Uyeki; David L Swerdlow; Maha Barakat; Sherif R Zaki
Journal:  Am J Pathol       Date:  2016-02-05       Impact factor: 4.307

Review 8.  Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.

Authors:  Jie Li; Jian-Gao Fan
Journal:  J Clin Transl Hepatol       Date:  2020-03-30

9.  Evidence for Gastrointestinal Infection of SARS-CoV-2.

Authors:  Fei Xiao; Meiwen Tang; Xiaobin Zheng; Ye Liu; Xiaofeng Li; Hong Shan
Journal:  Gastroenterology       Date:  2020-03-03       Impact factor: 22.682

10.  Cutaneous manifestations in COVID-19: Lessons learned from current evidence.

Authors:  Poonkiat Suchonwanit; Kanchana Leerunyakul; Chaninan Kositkuljorn
Journal:  J Am Acad Dermatol       Date:  2020-04-24       Impact factor: 11.527

View more
  24 in total

1.  Overview of Nonhuman Primate Models of SARS-CoV-2 Infection.

Authors:  Anita M Trichel
Journal:  Comp Med       Date:  2021-09-21       Impact factor: 0.982

Review 2.  Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019.

Authors:  Jiayu Dai; Yibo Wang; Hongrui Wang; Ziyuan Gao; Ying Wang; Mingli Fang; Shuyou Shi; Peng Zhang; Hua Wang; Yingying Su; Ming Yang
Journal:  Front Microbiol       Date:  2022-06-27       Impact factor: 6.064

Review 3.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590

Review 4.  The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury.

Authors:  Giovanni Zarrilli; Valentina Angerilli; Gianluca Businello; Marta Sbaraglia; Giulia Traverso; Francesco Fortarezza; Stefania Rizzo; Monica De Gaspari; Cristina Basso; Fiorella Calabrese; Angelo Paolo Dei Tos; Matteo Fassan
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

Review 5.  Immune response scenario and vaccine development for SARS-CoV-2 infection.

Authors:  Mai H S Mohammad
Journal:  Int Immunopharmacol       Date:  2021-01-29       Impact factor: 5.714

6.  Placental pathology and fetal demise at 35 weeks of gestation in a woman with SARS-CoV-2 infection: A case report.

Authors:  Tiffany M Poisson; Gerald Pierone
Journal:  Case Rep Womens Health       Date:  2021-01-28

7.  Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib.

Authors:  Arthur E Frankel; Renuka Reddy; Kayla R DeSuza; Khaled Deeb; Aaron F Carlin; Davey Smith; Yushuang Xie; Eknath Naik; Richard T Silver; Hans C Hasselbalch
Journal:  Clin Case Rep       Date:  2021-03-07

Review 8.  Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients.

Authors:  Wattana Leowattana
Journal:  World J Virol       Date:  2021-05-25

Review 9.  Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives.

Authors:  Hidefumi Inaba; Toru Aizawa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

10.  Neurological features and outcome in COVID-19: dementia can predict severe disease.

Authors:  Mehran Ghaffari; Hossein Ansari; Nahid Beladimoghadam; Seyed Hossein Aghamiri; Mehrdad Haghighi; Mahmoud Nabavi; Behnam Mansouri; Masoud Mehrpour; Farhad Assarzadegan; Omid Hesami; Meghdad Sedaghat; Mohammad Farahbakhsh; Behnam Safarpour Lima
Journal:  J Neurovirol       Date:  2021-01-08       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.